Docetaxel/trastuzumab: Nail dystrophy: case report

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1132, 2006-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel: Nail toxicity: case report

By  

Reactions Weekly, Vol. 1, Iss. 1374, 2011-01 ,pp. : 16-17

Adis International

Access to resources Recommend Favorite

Docetaxel/lapatinib/trastuzumab: Pneumothoraces: case report

By  

Reactions Weekly, Vol. 1, Iss. 1336, 2011-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

Cyclophosphamide/docetaxel/doxorubicin/trastuzumab: Lymphoedema (first report for cyclophosphamide and trastuzumab): case report

By  

Reactions Weekly, Vol. 1, Iss. 1361, 2011-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Docetaxel/trastuzumab combination therapy for the treatment of breast cancer

By Nabholtz Jean-marc   Gligorov Joseph  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1555-1564

Informa Healthcare

Access to resources Recommend Favorite

Docetaxel/lapatinib/trastuzumab: Acute respiratory distress syndrome in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1325, 2010-01 ,pp. : 14-15

Adis International

Access to resources Recommend Favorite